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GlomerulogenesisThe PKD1 gene is essential for a number of biological functions, and its loss-of-function causes autosomal
dominant polycystic kidney disease (ADPKD). The gene is developmentally regulated and believed to play
an essential role in renal development. Previous studies have shown that manipulating murine renal
organ cultures with dominant-negative forms of the Pkd1 gene impaired ureteric bud (UB) branching.
In the current study, we analyzed different stages of renal development in two distinct mouse models
carrying either a null mutation or inactivation of the last two exons of Pkd1. Surprisingly, metanephric
explants from Pkd1-deleted kidneys harvested at day E11.5 did not show defects of UB branching and
elongation, estimated by cytokeratin staining on ﬁxed tissues or by Hoxb7-GFP time-lapse imaging. How-
ever, renal explants from Pkd1-mutants isolated at day E14.5 showed impaired nephrogenesis. Notably,
we observed cell migratory defects in the developing endothelial compartment. Previous studies had
implicated the Pkd1 gene in controlling cell migration and collagen deposition through PI3 kinases. In line
with these studies, our results show that wild-type explants treated with PI3-kinase inhibitors recapitu-
late the endothelial defects observed in Pkd1 mutants, whereas treatment with VEGF only partially res-
cued the defects. Our data are consistent with a role for the Pkd1 gene in the endothelium that may be
required for proper nephrogenesis.
 2014 The Authors. Published by Elsevier Inc. Open access under CC BY-NC-ND license.1. Introduction
Autosomal dominant polycystic kidney disease (ADPKD) is one
of the most common monogenic disorders with an incidence of 1/
500–1/1000. The disease is characterized by the formation of bilat-
eral ﬂuid-ﬁlled cysts, which originate from every segment of the
nephron [1,2]. ADPKD is, however, a systemic disorder because
cyst formation is observed in other organs, such as the liver and
the pancreas. In addition, numerous vascular abnormalities were
reported including intracranial aneurysms, aortic root dilatation,
aneurysm and mitral valve prolapses [2]. The disease is caused
by a mutation in the PKD1 gene in 85% of the cases and in the
PKD2 gene in the remaining cases [1]. The PKD1 gene product, Poly-
cystin-1 (PC-1), is a large plasma membrane protein
(approximately 520 kDa) that forms a functional complex withthe PKD2 gene product Polycystin-2 (PC-2), a non-selective cation
channel [2]. The polycystin complex functions in the primary cil-
ium, where it is believed to act as a mechanosensor that controls
the Ca2+ inﬂux provoked by mechanical stimuli [3].
Numerous mouse models carrying null and/or hypomorphic al-
leles of the Pkd1 gene have been generated, which share very sim-
ilar phenotypes [4–10]. The mice harboring homozygous
mutations inactivating the Pkd1 gene die during the fetal stage
and invariably develop renal cysts by E15.5. These homozygous
mutant embryos also show cardiovascular and heart defects, hy-
drops fetalis, and bone defects [4,7,8]. Mice heterozygous for the
mutations survive after birth and display late-onset polycystic kid-
ney and liver disease with very few renal cysts [4–8].
The Pkd1 gene is developmentally regulated and is postulated to
be an important player in renal development. Development of the
kidney initiates when an outpouching of the Wolfﬁan duct, called
the ureteric bud (UB), invades the metanephric mesenchyme
(MM) at around day E11.5 in the mouse. After the UB invades
the MM, it undergoes branching followed by elongation of the col-
lecting duct [11]. Each UB tip will induce condensation of the
metanephric mesenchyme, which eventually epithelializes to form
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tion have occurred, precursors of the endothelial compartment mi-
grate towards the nascent tubule and eventually form the
glomerular tuft.
Two previous studies had implied a role for the Pkd1 gene and
its product PC-1 in UB branching and early morphogenesis during
renal development using two different strategies to impair PC-1
function. Treatment of kidney rudiments with a peptide derived
from a highly conserved sequence in the PKD repeats of PC-1
(WDGFDG) or the overexpression of the C-terminal domain of
PC-1 in the UB prevented correct branching morphogenesis in a
model of ex vivo embryonic murine kidney explants [12,13].
In the current study, we have performed similar renal organ
culture experiments to investigate the role of the Pkd1 gene in re-
nal development. Rather than manipulate wild-type organ cul-
tures, we chose to use mouse models in which the Pkd1 gene has
been genetically inactivated. Renal explants derived from Pkd1mu-
tant mice do not develop cysts ex vivo unless analogues of cAMP
are added to the culture medium [14]. We show that renal rudi-
ments harvested at day E11.5, Pkd1/ kidneys do not show defects
in UB branching and elongation. However, in Pkd1/ E14.5 ex-
plants, we observed impaired glomerulogenesis, possibly due to
defective endothelial cell migration.2. Materials and methods
2.1. Mice crosses
All animal care and experimental protocols were conducted in
accordance with the guidelines provided by the Italian Ministry
of Health, upon approval of a speciﬁc protocol (IACUC-548) by
the institutional care and use ethical committee (I.A.C.U.C.) at the
San Raffaele Scientiﬁc Institute.
The Pkd1 null mouse model and the Pkd1DC mouse model were
previously described [9,10]. For the culture of kidneys at 11.5 days
Pkd1 Bl6/57 were crossed whereas culture of kidneys at 14.5 days
mice were 50% FVB–50% Bl6/57. The mice Pkd1DC/+ in 100% Bl6/57
were crossed to harvest the kidneys at day E14.5. The Hoxb7-GFP
mice were kindly provided by Dr. Frank Costantini [15]. Noon the
day when the vaginal plug was observed was considered to be
embryonic day E0.5.
2.2. Embryonic kidney explant cultures
Kidney rudiments have been isolated from mouse embryos at
day E11.5 or at day E14.5 in CO2 independant medium (Gibco Cat
#18045-088) kept on ice and cultured in Dulbecco’s Modiﬁed Ea-
gle’s Medium supplemented with 10% fetal bovine serum and Pen-
icillin/streptomycin on polyester membrane ﬁlters of 0.4 mm pore
size, (Transwell, Costar). After 3 days, the tissues were ﬁxed in
20 C methanol 10 min at room temperature and processed for
whole mount immunoﬂuorescence. For PI3kinase inhibition or
VEGF treatment, cultures were incubated with 10 lM LY294002
(Promega, Madison, WI) or 25 ng/ml VEGF (R&D).
For time-lapse video microscopy, explants were recorded using
a Nikon Elipse TE2000 microscope equipped with an Evolution VF
digital camera. The control unit allows mixing of humidiﬁed air
with CO2 at deﬁned ratios (typically 95% air/5% CO2). A water bath
regulated by a software maintains the temperature at 37 C.
2.3. Immunoﬂuorescence
For Immunoﬂuorescence, sections or rudiments were rehy-
drated, permeabilised in PBS/0.1% Triton X-100 blocked with 5%
goat serum (Sigma)/3% BSA/PBS, incubated with primaryantibodies 1 h at 37 C or overnight at 4 C. Kidneys are washed
in PBS, incubated with 1/1000 Alexa Fluor-488 or Alexa Fluor-
594 conjugated secondary antibody (Molecular Probe) for 1 h RT,
washed in PBS, mounted in glycerol/anti-fade/PBS. Digital images
were obtained with a Zeiss microscope. Primary antibodies used
were anti pan-cytokeratin from Sigma, (St. Louis, MO; C2562) Lam-
inin from Sigma (St. Louis, MO; C2562) L9393), E-cadherin (BD
Transduction Laboratories 610181), WT1 from Santa Cruz Biotech-
nology (Santa Cruz, CA; sc192), NCAM (Chemicon international
MAB310).
2.4. Statistical analysis of results
Student’s t test was used to analyze differences between groups.3. Results
3.1. No early defects in UB branching of Pkd1/ kidneys
We investigated whether early nephrogenesis was altered in a
previously described Pkd1-null mouse model [9]. Ex-vivo organ cul-
tures of metanephric explants from control and mutant embryos
were initiated at day E11.5, cultured for 3 days and stained for
cytokeratin, a marker of the UB. A quantiﬁcation analysis did not
show defects in UB branching and elongation in Pkd1/ kidneys
compared to the Pkd1+/+ and the Pkd1+/ kidneys (Fig. 1A). Like-
wise, the number of ureteric bud tips was not statistically different
(Fig. 1F). Pkd1+/+, Pkd1+/, and Pkd1/ explants were stained for
cytokeratin and laminin, which revealed comma-shaped and S-
shaped bodies. Pkd1/ explants did not display major defects in
early nephrogenesis at this stage compared to control explants
(Fig. 1B and C). To more carefully study potentially mild defects
and to measure kinetic parameters of branching morphogenesis,
we performed real-time analysis on the Pkd1-null mice inter-
crossed with Hoxb7-GFP transgenic mice, which expressed the
green ﬂuorescent protein (GFP) reporter speciﬁcally in the UB epi-
thelium [15]. Kidneys harvested at day E11.5 were placed in cul-
ture, and the branching of the UB was followed for 3 days using
time-lapse video microscopy [15,16]. Based on conventional stan-
dards, the initial bud that evaginated from the Wolfﬁan duct was
considered a ﬁrst-generation event, and the following characteris-
tic ‘‘T-shape’’ was considered as time 0 [16]. Seven images of each
culture of Pkd1+/+ and Pkd1/ metanephric explants at 10-h inter-
vals (from 0 to 60 h) were analyzed (Fig. 1D and E, respectively).
These images showed no differences in kinetics in the branching
morphogenesis between Pkd1+/+ and Pkd1/ organ cultures iso-
lated from littermates (movies 1 and 2, respectively; Pkd1+/+
n = 4, Pkd1+/ n = 8, and Pkd1/ n = 13 in four independent litters).
3.2. Defective nephrogenesis in Pkd1/ explants
Next, we stained explants for WT1, which is expressed in the
condensing mesenchyme and in precursors of podocytes. This
staining revealed a reduced number of glomeruli in Pkd1/ ex-
plants (Fig. 2C, F and H) compared to those in the Pkd1+/+
(Fig. 2A, D and G) and Pkd1+/ explants (Fig. 2B and E). There was
a signiﬁcant decrease in the number of glomeruli (a 52% reduction)
in the Pkd1/ explants compared to that of the Pkd1+/+ explants,
respectively 91 +/- 17 and 189 +/- 31 (Fig. 2I). However, the num-
ber of condensed mesenchyme was increased in the Pkd1/ kid-
neys (Fig. 2F) as compared to the controls (Fig. 2D and E),
suggesting that the delay in nephron maturation is not caused by
defects in the mesenchymal condensation. Similar results were ob-
tained when using the Pkd1DC/DC mouse model [10] (not shown),
excluding the possibility that the mouse model itself, and not the
Fig. 1. No early UB branching defects in Pkd1/ compared to Pkd1+/+ and Pkd1+/ explants. (A–E) Metanephric explants from embryos of 11.5 days were cultured for 3 days.
(A) Staining for cytokeratin (green), marker of the UB epithelium in Pkd1+/+, Pkd1+/ and Pkd1/ renal explants shows similar UB elongation and branching. (B) Laminin
staining (red), which marks the basement membranes of epithelializing structures, of the kidney rudiments isolated at day E11.5 and cultured for 3 days, does not show
defects of early nephrogenesis. (C) Merge of cytokeratin and laminin. (D and E) Time-lapse video microscopy for up to 60 h of Pkd1+/+(D) or Pkd1/. (E) Hoxb7-GFP transgenic
kidneys isolated at E11.5 show normal kinetics of UB branching and elongation of Pkd1/ explants. (F) Quantiﬁcation of UB tips number of renal explants isolated at E11.5
and cultured for 3 days. Means ± SD are given; n.s.: no signiﬁcant; n indicates the number of kidneys. Counts were performed on four independent litters. (Bar = 500 lm). (For
interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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Pkd1DC/DC mice survived for longer times in a pure genetic back-
ground [10], this second set of experiments was conducted in a
pure Bl6/C57 background to exclude the possibility that the genetic
background inﬂuenced the outcome.
3.3. Defective endothelial cell migration in Pkd1/ explants
Correct nephrogenesis requires precise crosstalk between the
UB branching and the condensing mesenchyme. However, neither
UB branching nor the structures derived from the condensing mes-
enchyme (comma- and S-shape bodies) were grossly affected in
the Pkd1 mutant kidneys (Fig. 1, Supplementary Fig. 1 and
Fig. 3A). A third essential component for glomerulogenesis is the
endothelium, which migrates toward the nascent glomerulus to
contribute to its maturation (Fig. 3A) [17]. We have previouslyreported that PC-1 mediates cell migration in epithelial cells and
ﬁbroblasts [18]. Furthermore, a recent study has shown that PC-1
plays an essential role in the endothelial compartment [19]. There-
fore, we hypothesized that the defective endothelial cell migration
in the developing kidney accounts for the defective glomerulogen-
esis. Staining with anti-CD31 identiﬁed an interconnection of
endothelial cells with WT-1-positive cells in the renal rudiments
isolated at E14.5 and cultured for 3 days (Fig. 3B and movie 3). In
addition, an abundant number of CD31-positive cells were migrat-
ing on the ﬁlter that surrounded the renal cultures. Notably, CD31-
positive migrating cells were very abundant in Pkd1+/+ explants
(Fig. 3C and C0), whereas they were impaired in Pkd1/ explants
(Fig. 3D and D0; n = 9; seven independent litters). Quantiﬁcation re-
vealed that cells migrating out of the renal explants were strongly
reduced in the Pkd1/ explants compared to controls (Fig. 3E) and
that CD31-positive cells were more affected than the other
Fig. 2. Impaired nephrogenesis in Pkd1/ cultured kidneys. (A–F) Kidneys withdrawn at E14.5 and cultured for 72 h were stained for WT1 (red), marker of condensed
mesenchyme (arrow) and glomeruli (arrowhead). Two different magniﬁcations of Pkd1+/+ (A and D), Pkd1+/ (B and E) and Pkd1/ (C and F) revealed decreased glomeruli
(arrowheads) and increased condensed mesenchyme (arrows) in Pkd1/ as compared to Pkd1+/ and Pkd1+/+ explants. (G and H) Co-staining of cytokeratin (green) and WT1
(red) showing more abundant glomeruli in Pkd1+/+ kidneys (G) compared to the Pkd1/ explants (H), whereas there is more condensed mesenchyme in the mutant compared
to the wt. (I) The number of the glomeruli in Pkd1/ kidneys is signiﬁcantly impaired compared to the Pkd1+/+ and Pkd1+/ kidneys. Means ± SD are given; n.s.: no signiﬁcant
P > 0.05; ⁄⁄⁄P < 0.001. n indicated corresponds to the number of kidneys. Experiments were carried out on three independent litters. (A–C) Bar = 500 lm, (F–H) Bar = 200 lm).
(For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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results indicate a defect in the migration of renal embryonic endo-
thelial cells that may cause defective glomerulogenesis (Fig. 3A).3.4. PI3-kinase inhibitors phenocopy the defective endothelial cell
migration and glomerulogenesis observed in Pkd1/ explants
We previously reported that PC-1 induces cell migration of epi-
thelial cells and ﬁbroblasts in a phosphatidylinositol-3-kinase (PI3-
kinase)-dependent manner [18]. Therefore, we hypothesized that
the absence of the Pkd1 gene in endothelial cells might cause the
defective PI3-kinase-dependent migration of the CD31-positive
population of cells. Treatment of the renal organ cultures with
10 lM LY294002, a PI3-kinase inhibitor (Fig. 4B), completely abol-
ished the movement of endothelial cells out of the kidney and
caused defective nephrogenesis (Fig. 4E and F). These observations
were similar to those made in Pkd1/ organ cultures (Fig. 3D andE). Notably, treating Pkd1/ renal organ cultures with VEGF pro-
moted elongation and migration of the few CD31-positive cells
out of the organ cultures (Fig. 4K). However, VEGF treatment did
not completely rescue the migration phenotype, which suggested
that the CD31-positive cells response to VEGF is blunted in Pkd1
mutant explants.4. Discussion
Previous studies have proposed that PC-1 may play a major role
in early kidney development and UB branching morphogenesis.
Microinjection into the developing UB of a lentiviral construct con-
taining a putative dominant-negative form of PC-1, which encodes
a myristoylated form of its intracellular C-terminus fused to GFP
(pMyr-GFP-C-terminal), signiﬁcantly decreased ureteric bud elon-
gation and branching morphogenesis in metanephric explants cul-
tured at day E11.5 [13].
Fig. 3. Impaired endothelial migration out of the Pkd1/ cultured kidneys. (A) Schematic representation of early nephrogenesis. The UB undergoes a series of branching
events (1). Each UB tip will induce mesenchymal condensation, comma (2) and s-shaped bodies (3) formation. The S-shaped body secretes VEGF attracting endothelial cells
(E.C.) which eventually form the glomerular tuft (4). The last event might be affected in Pkd1mutant explants. (B) Kidneys isolated at E14.5 and cultured for 72 h were stained
for CD31 (green), marker of endothelial cells, and WT-1 (red), marker of maturing podocytes. (C and D) Kidneys isolated at E14.5 and cultured for 72 h were stained for CD31,
marker of endothelial cells. (C) CD31-positive cells migrated out of the renal explants in Pkd1+/+ kidneys (arrows) whereas the DAPI staining shows numerous cells migrating
out of the cultures (arrowheads). (D) CD31-positive cells did not migrate out of the renal Pkd1/ explants or formed only short protrusions (arrow). Non-endothelial cells
were also impaired in their migration, but to a lower extent (arrowhead). (C0 and D0) Zoom of the CD31 positive protrusions of the Pkd1+/+ kidneys (C0) and Pkd1/ (D0). (E) The
quantity of endothelial cells out of the explants was monitored measuring the area positive for CD31. The area of the Pkd1/ kidneys was signiﬁcantly reduced compared to
the area of the Pkd1+/+ kidneys. The migration rates of non-endothelial cells (DAPI-positive, CD31-negative) was established by measuring the distance (in lm) migrated from
the renal rudiment. Means ± SD are given; ⁄⁄⁄P < 0.001. n indicated corresponds to the number of kidneys. Bar = 100 lm. (For interpretation of the references to colour in this
ﬁgure legend, the reader is referred to the web version of this article.)
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presence of a peptide, which was derived from a highly conserved
sequence in the PKD repeats of PC-1 (WDGFDG), prevented proper
branching morphogenesis in a model of ex vivo embryonic murine
kidney explants [12]. The authors concluded that ureteric bud
branching required correct PC-1 function. There was no direct evi-
dence for a role for the Pkd1 gene in UB branching using genetically
modiﬁed mice. In the current study, we have used two different
mouse models that carry the inactivation of the Pkd1 gene. Our re-
sults show that PC-1 is not involved in the initial steps of kidney
development, which include UB branching and early nephrogene-
sis. Furthermore, crossing Pkd1mutants with a transgenic line har-
boring a Hoxb7-GFP transgene allowed us to perform time-lapse
analysis of UB branching in Pkd1mutant kidneys. Our results dem-
onstrate that there are no differences in the kinetics or morphology
of UB branching.
Our ﬁndings cannot exclude a role for PC-1 in UB branching
morphogenesis in vivo, which are much harder to quantify. How-
ever, our results strongly suggest that previous work that also used
renal organ cultures may have introduced artifactual effects due to
the manipulations performed and/or interference with genes other
than Pkd1 itself.
We have found that functional Pkd1 is essential in the later
stages of renal development. The numbers of condensed mesen-
chymal vesicles and the comma- and S-shaped bodies were not de-
creased in two different Pkd1 mutant mouse models, suggesting
that mesenchymal condensation occurred normally, as previously
postulated [4]. However, the subsequent maturation of the S-
shaped bodies into glomeruli is speciﬁcally impaired in Pkd1mutant kidneys. Our data suggest that this effect may be caused
by the defective migration of endothelial cells to form the mature
glomerulus. Endothelial cell migration is necessary for proper
nephrogenesis to occur. During glomerulogenesis, the podocyte
precursors attract the endothelial cells into the proximal cleft by
secreting the chemoattractant VEGF [17,20]. In line with this, inac-
tivation of VEGF-A in the glomeruli induces defects in endothelial
cell migration, differentiation and survival, which ultimately inhib-
its the development of a ﬁltration barrier [21]. Our current study
shows that Pkd1-mutant endothelial cells (CD31-positive) derived
from the metanephric organ cultures are impaired in their capabil-
ity to migrate. Treatment with VEGF enhances elongation and
migration of the few endothelial cells that successfully migrate
out of the rudiment. However, VEGF does not signiﬁcantly rescue
the migration phenotype. The expression levels of VEGF-A in these
mutant organ cultures did not appear to be altered as compared to
wild-type organ cultures (not shown). Taken together, these re-
sults suggest that the defective production or secretion of VEGF
by the proximal cleft is unlikely to be the primary cause of failure
in migration. However, the defects in VEGF-A sensitivity by Pkd1
mutant endothelial cells may be a plausible explanation to ac-
count, at least in part, for the effect on cell migration.
The endothelial phenotype that we describe in the current
study is in line with the dramatic vascular phenotype observed
in all of the Pkd1 mutant models [7,6,22,9]. In addition, PC-1 local-
izes to primary cilia and mediates the sensitivity of endothelial
cells to ﬂuid shear stress by regulating calcium signaling and nitric
oxide production [23]. Furthermore, a recent study has provided
deﬁnitive evidence for a primary role of the Pkd1 gene in the
Fig. 4. Treatment of renal explants with PI3-kinase inhibitors copies defective Pkd1/ endothelial cell migration. (A–G) Pkd1+/+ renal explants isolated at E14.5 were cultured
for 72 h in the presence (B, D and F) or absence (A, C and E) of the PI3kinase inhibitor LY294002 (LY) at 10 lM. Staining for CD31 shows reduced CD31-positive cells migrating
out of the LY treated explants (B and D) as compared to the control (A and C). The CD31-positive area of the LY treated explants was signiﬁcantly reduced compared to the
area of the control kidneys (G). Staining for WT1 shows reduced glomeruli (arrowheads) and increased condensed mesenchyme (arrows) in LY treated explant (F) compared
to the control (E). (C and D) Zoom of the CD31 positive protrusions of the Pkd1+/+ kidneys (C) and LY (D) treated renal explants. (G) The endothelial cells migrating out of the
explants were quantiﬁed measuring the area positive for CD31 in LY-treated explants compared to the control. (H–K) Renal explants of Pkd1+/+ (H and I) and Pkd1/ (J and K)
kidneys cultured for 72 h with VEGF 25 ng/ml (I and K) or without VEGF (H and J) and stained for CD31. The phenotype of impaired migration in Pkd1/ renal explants was
not rescued by the VEGF treatment, although the protrusions are longer. Means ± SD are given; ⁄⁄⁄P < 0.001.n corresponds to the number of kidneys. Bar = 100 lm.
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line [19]. Our current work shows that defects in the endothelial
compartment of the developing kidney might result in the defec-
tive glomerulogenesis in Pkd1 mutant mice.
Garcia-Gonzalez et al. did not report the development of defec-
tive glomerulogenesis; however, it should be noted that a careful
analysis of the glomeruli in these mice was not performed, and it
was not determined if Tie2 is expressed by the endothelium in
the developing kidneys, whereas Tie1 has been shown to be very
abundant. Future studies should focus on inactivating the Pkd1
gene using a line carrying a Cre-recombinase expressed by the
angioblasts of the developing kidney.
Our previous work has shown that PC-1 regulates cell migration
both in epithelial cells and in ﬁbroblasts [18] through a mechanism
that depends on PI3-kinase-mediated regulation of the actin cyto-
skeleton. Our current work shows that PC-1 is essential for cell
migration in endothelial cells in a process that also likely depends
on PI3-kinase. Notably, a recent study has shown that morpholinos
against the two Pkd1 orthologues in Zebraﬁsh (Pkd1a and b) results
in the defective production and deposition of collagen through a
mechanism that requires PI3-kinase [24]. In their study, Mangos
et al. observed that, similar to our current work, inhibitors of
PI3-kinase activity phenocopy the effect of a lack of functional
Pkd1, which reinforces the idea that PI3-kinase might be an essen-
tial mediator of PC-1 activity.
In conclusion, our study has uncovered a potential function for
PC-1 in the endothelial compartment in the developing kidney,
which is likely important for proper glomerulogenesis.Statement of competing ﬁnancial interests
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